SFI Advisors’s Cryo-Cell International CCEL Stock Holding History

SFI Advisors’s Portfolio CCEL Stock Details CCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$694K	Hold	165,300	–	–	0.57%	38
2026 Q2	$527K	Hold	165,300	–	–	0.45%	39
2026 Q1	$587K	Hold	165,300	–	–	0.62%	38
2025 Q4	$569K	Hold	165,300	–	–	0.36%	42
2025 Q3	$767K	Hold	165,300	–	–	0.49%	40
2025 Q2	$858K	Hold	165,300	–	–	0.59%	37
2025 Q1	$1.05M	Hold	165,300	–	–	0.78%	31
2024 Q4	$1.22M	Hold	165,300	–	–	0.86%	28
2024 Q3	$1.05M	Hold	165,300	–	–	0.75%	33
2024 Q2	$1.26M	Hold	165,300	–	–	0.97%	28
2024 Q1	$1.23M	Hold	165,300	–	–	0.97%	29
2023 Q4	$950K	Hold	165,300	–	–	0.81%	33
2023 Q3	$869K	Hold	165,300	–	–	0.85%	35
2023 Q2	$1.01M	Hold	165,300	–	–	0.95%	33
2023 Q1	$499K	Hold	165,300	–	–	0.5%	38
2022 Q4	$699K	Hold	165,300	–	–	0.76%	38
2022 Q3	$1.01M	Hold	165,300	–	–	1.17%	29
2022 Q2	$975K	Hold	165,300	–	–	1.08%	28
2022 Q1	$1.26M	Hold	165,300	–	–	0.77%	27
2021 Q4	$1.57M	Buy	+165,300	New	+$2.06M	1.38%	26

Other funds holding CCEL

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

SFI Advisors's CCEL Position: Q3 2026 in Review

SFI Advisors held its Cryo-Cell International (CCEL) position steady in Q3 2026 at 165,300 shares worth $694K. The position accounts for 0.57% of the portfolio, ranked #38.

SFI Advisors first reported a position in CCEL in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.57M in Q4 2021. 2 funds tracked by Wall St. Rank hold CCEL as of Q3 2026.

SFI Advisors held 165,300 shares of Cryo-Cell International worth $694K as of Q3 2026.
SFI Advisors left its Cryo-Cell International share count unchanged in Q3 2026.
Cryo-Cell International made up 0.57% of SFI Advisors's portfolio in Q3 2026, its #38 holding.
SFI Advisors first reported a position in Cryo-Cell International in Q4 2021 and has held it in 20 quarters since.
SFI Advisors's Cryo-Cell International position peaked at $1.57M in Q4 2021.
2 funds tracked by Wall St. Rank held Cryo-Cell International as of Q3 2026.

Based on SFI Advisors's 13F filing for Q3 2026, filed 30 Oct 2026.